-
1 Comment
ShanXi C&Y Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 1.6% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
ShanXi C&Y Pharmaceutical Group Co., Ltd's total revenue sank by 21.6% to $205M since the same quarter in the previous year.
Its net income has dropped by 26.6% to $-48M since the same quarter in the previous year.
Finally, its free cash flow fell by 84.9% to $4M since the same quarter in the previous year.
Based on the above factors, ShanXi C&Y Pharmaceutical Group Co., Ltd gets an overall score of 1/5.
| ISIN | CNE1000016D0 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHE |
| CurrencyCode | CNY |
| Market Cap | 2B |
|---|---|
| PE Ratio | 65.5 |
| Target Price | None |
| Beta | 0.16 |
| Dividend Yield | None |
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Fluoxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Montmorillonite powder, Varenicline tartrate tablets, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as salt acid glucosamine raw material product. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to ShanXi C&Y Pharmaceutical Group Co.,LTD. in September 2014. The company was founded in 2005 and is based in Datong, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300254.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
